Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1318

1.

Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.

Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD.

J Infect Dis. 2005 Dec 15;192(12):2039-44. Epub 2005 Nov 8.

2.

Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.

Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE.

Sex Transm Dis. 2010 Jul;37(7):440-4. doi: 10.1097/OLQ.0b013e3181cfcd8c.

PMID:
20351623
3.

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.

Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS.

Clin Infect Dis. 2007 Jan 1;44(1):13-22. Epub 2006 Nov 27.

4.

The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L.

Clin Infect Dis. 2007 Nov 15;45(10):1319-26. Epub 2007 Oct 15.

5.

Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.

Helms DJ, Mosure DJ, Metcalf CA, Douglas JM Jr, Malotte CK, Paul SM, Peterman TA.

Sex Transm Dis. 2008 May;35(5):484-8. doi: 10.1097/OLQ.0b013e3181644b9c.

PMID:
18360314
6.

Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.

Upcroft JA, Dunn LA, Wal T, Tabrizi S, Delgadillo-Correa MG, Johnson PJ, Garland S, Siba P, Upcroft P.

Sex Health. 2009 Dec;6(4):334-8. doi: 10.1071/SH09011.

PMID:
19917203
7.

Trichomonas vaginalis as a cause of urethritis in Malawian men.

Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I.

Sex Transm Dis. 1999 Aug;26(7):381-7.

PMID:
10458630
8.

Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.

Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS.

J Infect Dis. 2008 Feb 15;197(4):548-54. doi: 10.1086/526496.

9.
10.

The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.

Konje JC, Otolorin EO, Ogunniyi JO, Obisesan KA, Ladipo OA.

Afr J Med Med Sci. 1991 Mar;20(1):29-34.

PMID:
1905467
11.

Trichomoniasis and its treatment.

Nanda N, Michel RG, Kurdgelashvili G, Wendel KA.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):125-35. Review.

PMID:
16441214
12.

Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs.

Caliendo AM, Jordan JA, Green AM, Ingersoll J, Diclemente RJ, Wingood GM.

Infect Dis Obstet Gynecol. 2005 Sep;13(3):145-50.

13.

Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.

Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, Ernest JM, Heine RP, Wapner RJ, Trout W, Moawad A, Leveno KJ, Miodovnik M, Sibai BM, Van Dorsten JP, Dombrowski MP, O'Sullivan MJ, Varner M, Langer O, McNellis D, Roberts JM; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

N Engl J Med. 2001 Aug 16;345(7):487-93.

14.

Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.

Roth AM, Williams JA, Ly R, Curd K, Brooks D, Arno J, Van Der Pol B.

Sex Transm Dis. 2011 May;38(5):398-400. doi: 10.1097/OLQ.0b013e318203e3ce.

PMID:
21217417
15.

Premature with trichomoniasis: report of one case.

Wang JJ, Yeung LK, Sun LC, Sy LB, Leu FJ.

Acta Paediatr Taiwan. 2005 Jul-Aug;46(4):219-21.

PMID:
16381336
16.

A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis.

duBouchet L, McGregor JA, Ismail M, McCormack WM.

Sex Transm Dis. 1998 Mar;25(3):176-9.

PMID:
9524997
17.

A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania.

Klinger EV, Kapiga SH, Sam NE, Aboud S, Chen CY, Ballard RC, Larsen U.

Sex Transm Dis. 2006 Dec;33(12):712-8.

PMID:
16755271
18.

A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, Schmidt N, Rosenthal SL, Myers L, Martin DH.

J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):565-71. doi: 10.1097/QAI.0b013e3181eda955.

19.

Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates.

Sutcliffe S, Newman SB, Hardick A, Gaydos CA.

Sex Transm Dis. 2010 Sep;37(9):585-90.

20.

Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.

Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H.

J Reprod Med. 2001 Jun;46(6):545-9.

PMID:
11441678
Items per page

Supplemental Content

Write to the Help Desk